Parametric Portfolio Associates’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-262,451
| Closed | -$5.11M | – | 4050 |
|
|
2018
Q1 | $5.11M | Buy |
262,451
+275
| +0.1% | +$5.4K | 0.01% | 1884 |
|
|
2017
Q4 | $4.37M | Buy |
262,176
+36,008
| +16% | +$660K | ﹤0.01% | 2018 |
|
|
2017
Q3 | $4.59M | Buy |
226,168
+17,051
| +8% | +$326K | 0.01% | 1911 |
|
|
2017
Q2 | $3.37M | Buy |
209,117
+59,868
| +40% | +$884K | ﹤0.01% | 2127 |
|
|
2017
Q1 | $1.89M | Buy |
149,249
+70,044
| +88% | +$846K | ﹤0.01% | 2481 |
|
|
2016
Q4 | $1.05M | Buy |
79,205
+9,600
| +14% | +$164K | ﹤0.01% | 2804 |
|
|
2016
Q3 | $1.65M | Sell |
69,605
-10,150
| -13% | -$273K | ﹤0.01% | 2475 |
|
|
2016
Q2 | $2.3M | Buy |
79,755
+25,006
| +46% | +$815K | ﹤0.01% | 2224 |
|
|
2016
Q1 | $1.75M | Sell |
54,749
-4,219
| -7% | -$148K | ﹤0.01% | 2507 |
|
|
2015
Q4 | $2.52M | Sell |
58,968
-4,199
| -7% | -$168K | ﹤0.01% | 2041 |
|
|
2015
Q3 | $2.22M | Sell |
63,167
-26,784
| -30% | -$1.21M | ﹤0.01% | 1765 |
|
|
2015
Q2 | $4.13M | Sell |
89,951
-4,196
| -4% | -$199K | 0.01% | 1541 |
|
|
2015
Q1 | $4.41M | Sell |
94,147
-3,506
| -4% | -$140K | 0.01% | 1450 |
|
|
2014
Q4 | $3.09M | Buy |
97,653
+7,556
| +8% | +$221K | 0.01% | 1719 |
|
|
2014
Q3 | $2.14M | Buy |
90,097
+5,211
| +6% | +$133K | ﹤0.01% | 2018 |
|
|
2014
Q2 | $2.55M | Sell |
84,886
-1,049
| -1% | -$28.3K | 0.01% | 1824 |
|
|
2014
Q1 | $2.27M | Buy |
85,935
+2,480
| +3% | +$62K | 0.01% | 1915 |
|
|
2013
Q4 | $2.1M | Buy |
83,455
+2,951
| +4% | +$65.8K | 0.01% | 1996 |
|
|
2013
Q3 | $1.65M | Buy |
80,504
+1,263
| +2% | +$26.1K | ﹤0.01% | 2122 |
|
|
2013
Q2 | $1.58M | Buy |
+79,241
| New | +$1.41M | ﹤0.01% | 2046 |
|
Parametric Portfolio Associates's IPXL Position: Q2 2018 in Review
Parametric Portfolio Associates sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 262,451 shares — an estimated $5.11M sold.
Parametric Portfolio Associates first reported a position in IPXL in Q2 2013 and held it in 20 quarters. The position peaked at $5.11M in Q1 2018. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.
- Parametric Portfolio Associates reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
- Parametric Portfolio Associates sold 262,451 Impax Laboratories, Inc. shares in Q2 2018, an estimated $5.11M.
- Parametric Portfolio Associates first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 20 quarters.
- Parametric Portfolio Associates's Impax Laboratories, Inc. position peaked at $5.11M in Q1 2018.
- 1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.
Based on Parametric Portfolio Associates's 13F filing for Q2 2018, filed 13 Aug 2018.